Jasper Therapeutics, Inc. (JSPR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Jasper Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.46x | -4.38x | -1.28x | -0.47x | -2.92x | -0.54x |
| P/B Ratio | 8.45x | 5.06x | 1.05x | 0.49x | 1.29x | -0.49x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 2.62x | 4.98x | 7.19x | 5.91x | 10.95x | 5.16x |
| Quick Ratio | 2.62x | 4.98x | 7.19x | 5.91x | 10.95x | 5.16x |
| Leverage | ||||||
| Debt/Equity | 0.30x | 0.03x | 0.04x | 0.10x | 0.04x | -0.05x |
YoY = year-over-year change. Source: FMP..